Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)UnknownNCT04277845
What this trial is testing

Randomized Phase II Study in Elderly Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Samsung Medical Center 49
Large-scale testing (Phase 3)UnknownNCT00910897
What this trial is testing

Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 205
Not applicableStudy completedNCT02946333
What this trial is testing

Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain

Who this might be right for
Multiple Myeloma
Celgene 355
Testing effectiveness (Phase 2)Active Not RecruitingNCT04564703
What this trial is testing

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

Who this might be right for
Multiple Myeloma
Stichting European Myeloma Network 160
Large-scale testing (Phase 3)Looking for participantsNCT05665140
What this trial is testing

Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma
University Hopsital Schleswig Holstein Campus Lübeck 100
Testing effectiveness (Phase 2)Study completedNCT02375555
What this trial is testing

Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07740486
What this trial is testing

A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease

Who this might be right for
Multiple Myeloma (MM)
Polish Myeloma Consortium 248
Testing effectiveness (Phase 2)UnknownNCT05422027
What this trial is testing

Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Xia Zhongjun 42
Testing effectiveness (Phase 2)Study completedNCT02046070
What this trial is testing

Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 148
Large-scale testing (Phase 3)Study completedNCT00416897
What this trial is testing

Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmRenal Failure
University of Glasgow 280
Testing effectiveness (Phase 2)Looking for participantsNCT07585760
What this trial is testing

CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

Who this might be right for
Multiple Myeloma (MM)Multiple Myeloma Light Chain Induced Renal Insufficiency
Institute of Hematology & Blood Diseases Hospital, China 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009109
What this trial is testing

Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

Who this might be right for
Myeloma, Multiple
Alliance Foundation Trials, LLC. 79
Large-scale testing (Phase 3)Study completedNCT05804032
What this trial is testing

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 514
Large-scale testing (Phase 3)UnknownNCT01554852
What this trial is testing

Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Leeds 4,420
Not applicableStudy completedNCT05284591
What this trial is testing

Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)

Who this might be right for
Multiple MyelomaNewly DiagnosedTransplant Ineligible+3 more
iOMEDICO AG 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05527340
What this trial is testing

Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 140
Testing effectiveness (Phase 2)Study completedNCT02272803
What this trial is testing

Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 82
Large-scale testing (Phase 3)Study completedNCT02215980
What this trial is testing

STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 210
Testing effectiveness (Phase 2)Study completedNCT02159365
What this trial is testing

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 84
Next Page